Determinants of influenza vaccination uptake in pregnancy: a large single-Centre cohort study

被引:22
作者
Bartolo, Stephanie [1 ,2 ]
Deliege, Emilie [3 ]
Mancel, Ophelie [3 ]
Dufour, Philippe [3 ]
Vanderstichele, Sophie [3 ]
Roumilhac, Marielle [3 ]
Hammou, Yamina [3 ]
Carpentier, Sophie [3 ]
Dessein, Rodrigue [4 ]
Subtill, Damien [1 ,3 ]
Faure, Karine [4 ,5 ]
机构
[1] Univ Lille, EA Epidemiol & Qual Soins 2694, Pole Rech, Aile Est 2eme Etage,1 Pl Verdun, F-59045 Lille, France
[2] Douai Hosp, Route Cambrai 10740, F-59507 Douai, France
[3] Univ Lille, CHU Lille, Pole Femme Mere Nouveaune, Ave Eugene Avinee, F-59000 Lille, France
[4] Univ Lille, EA7366, Rech Translat Relat Hote Pathogenes, Fac Med Pole Rech, 5 Eme Etage Ouest,1 Pl Verdun, F-59045 Lille, France
[5] Univ Lille, CHU Lille, Serv Malad Infect, Rue Michel Polonowski, F-59000 Lille, France
关键词
Influenza vaccine; Pregnancy; Health knowledge; Behaviours; PRETERM DELIVERY; COVERAGE; SAFETY; WOMEN; IMMUNIZATION; VACCINES; MOTHERS; ARM;
D O I
10.1186/s12884-019-2628-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Although vaccination of pregnant women against influenza is recommended, the vaccination rate remains low. We conducted a study to identify determinants of influenza vaccination uptake in pregnancy in order to identify strategies to improve seasonal influenza vaccination rates. Methods: Prospective observational hospital-based study in the French hospital performing the highest number of deliveries, located in the city of Lille, among all women who had given birth during the 2014-2015 influenza season. Data were collected through a self-completed questionnaire and from medical files. The vaccination uptake was self-reported. Determinants of vaccination uptake were identified using logistic regression analysis. Results: Of the 2045 women included in the study, 35.5% reported that they had been vaccinated against influenza during their pregnancy. The principal factors significantly associated with greater vaccination uptake were previous influenza vaccination (50.9% vs 20.2%, OR 4.1, 95% CI 3.1-5.5), nulliparity (41.0% vs 31.3%, OR 2.5, 95% CI 1.7-3.7), history of preterm delivery < 34 weeks (43.4% vs 30.3%, OR 2.3, 95% CI 1.1-4.9), the mother's perception that the frequency of vaccine complications for babies is very low (54.6% vs 20.6%, OR 1.1, 95% CI 0.5-2.2), the mother's good knowledge of influenza and its vaccine (61.7% vs 24.4%, OR 3.1, 95% CI 2.2-4.4), hospital-based prenatal care in their first trimester of pregnancy (55.0% vs 30.2%, OR 2.1, 95% CI 1.2-3.7), vaccination recommendations during pregnancy by a healthcare worker (47.0% vs 2.7%, OR 18.8, 95% CI 10.0-35.8), receipt of a vaccine reimbursement form (52.4% vs 18.6%, OR 2.0, 95% CI 1.5-2.7), and information from at least one healthcare worker about the vaccine (43.8% vs 19.1%, OR 1.8, 95% CI 1.3-2.6). Conclusions: Our findings suggest that in order to increase flu vaccination compliance among pregnant women, future public health programmes must ensure cost-free access to vaccination, and incorporate education about the risks of influenza and the efficacy/safety of vaccination and clear recommendations from healthcare professionals into routine antenatal care.
引用
收藏
页数:9
相关论文
共 24 条
[11]   The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review [J].
Giles, Michelle L. ;
Krishnaswamy, Sushena ;
Macartney, Kristine ;
Cheng, Allen .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) :687-699
[12]  
Ko Hyun Sun, 2015, Obstet Gynecol Sci, V58, P81, DOI 10.5468/ogs.2015.58.2.81
[13]   Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet [J].
Loubet, Paul ;
Guerrisi, Caroline ;
Turbelin, Clement ;
Blondel, Beatrice ;
Launay, Odile ;
Bardou, Marc ;
Goffinet, Francois ;
Colizza, Vittoria ;
Hanslik, Thomas ;
Kerneis, Solen .
VACCINE, 2016, 34 (20) :2390-2396
[14]   Safety of the 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Preterm delivery and specific malformations, a study from the case-control arm of VAMPSS [J].
Louik, Carol ;
Kerr, Stephen ;
Van Bennekom, Carla M. ;
Chambers, Christina ;
Jones, Kenneth L. ;
Schatz, Michael ;
Mitchell, Allen A. .
VACCINE, 2016, 34 (37) :4450-4459
[15]  
Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI [10.1056/NEJMoa1401480, 10.1056/NEJMc1412050]
[16]   Influenza vaccination during pregnancy: Coverage rates and influencing factors in two urban districts in Sydney [J].
Maher, Louise ;
Hope, Kirsty ;
Torvaldsen, Siranda ;
Lawrence, Glenda ;
Dawson, Angela ;
Wiley, Kerrie ;
Thomson, Deborah ;
Hayen, Andrew ;
Conaty, Stephen .
VACCINE, 2013, 31 (47) :5557-5564
[17]   Coverage and determinants of influenza vaccine among pregnant women: a cross-sectional study [J].
Offeddu, Vittoria ;
Tam, Clarence C. ;
Yong, Tze Tein ;
Tan, Lay Kok ;
Thoon, Koh Cheng ;
Lee, Nicole ;
Tan, Thiam Chye ;
Yeo, George S. H. ;
Yung, Chee Fu .
BMC PUBLIC HEALTH, 2019, 19 (1)
[18]   Influenza Vaccination, Pregnancy Safety, and Risk of Early Pregnancy Loss [J].
Sperling, Rhoda S. ;
Riley, Laura E. .
OBSTETRICS AND GYNECOLOGY, 2018, 131 (05) :799-802
[19]   Influenza Immunization in Pregnancy - Antibody Responses in Mothers and Infants [J].
Steinhoff, Mark C. ;
Omer, Saad B. ;
Roy, Eliza ;
Arifeen, Shams E. ;
Raqib, Rubhana ;
Altaye, Mekibib ;
Breiman, Robert F. ;
Zaman, Khalequ .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) :1644-1646
[20]   Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring [J].
Vellozzi, Claudia ;
Burwen, Dale R. ;
Dobardzic, Azra ;
Ball, Robert ;
Walton, Kimp ;
Haber, Penina .
VACCINE, 2009, 27 (15) :2114-2120